Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | +1.89% | -7.69% | -0.92% |
May. 09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
Financials (USD)
Sales 2024 * | 12.22M | Sales 2025 * | 5.87M | Capitalization | 204M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -35M | EV / Sales 2024 * | 16.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 34.7 x |
P/E ratio 2024 * |
-8.31
x | P/E ratio 2025 * |
-6.28
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on Lineage Cell Therapeutics, Inc.
1 day | +1.89% | ||
1 week | -7.69% | ||
Current month | -0.92% | ||
1 month | -10.00% | ||
3 months | -4.42% | ||
6 months | +13.68% | ||
Current year | -0.92% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Director/Board Member | 66 | 14-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.08 | +1.89% | 1,361,186 |
24-05-16 | 1.06 | -2.75% | 736,246 |
24-05-15 | 1.09 | +4.81% | 979,899 |
24-05-14 | 1.04 | -4.59% | 2,115,886 |
24-05-13 | 1.09 | -6.84% | 876,496 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.92% | 204M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- LCTX Stock